Get a grip on immune cells by inhibiting JAKs

JAK inhibitors are approved for myelofibrosis (MF) and polycythemia vera (PV), as they reverse inflammation-associated splenomegaly and symptoms. Notably, JAK inhibitors only marginally affect disease burden. The anti-inflammatory effects of JAK inhibitors affects DC, T and NK cells explaining their...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncoimmunology
Asıl Yazarlar: Schönberg, Kathrin, Rudolph, Janna, Yajnanarayana, Sowmya Parampalli, Wolf, Dominik
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2015
Konular:
Author's View
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4801466/
https://ncbi.nlm.nih.gov/pubmed/27057437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1071009
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller